Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 5 results.
User Information
Export Records
  1. 1.   The Evolution of Medical Countermeasures for Ebola Virus Disease: Lessons Learned and Next Steps
  2. Crozier,Ian; Britson, Kyla A; Wolfe, Daniel N; Klena, John D; Hensley, Lisa E; Lee, John S; Wolfraim, Larry A; Taylor, Kimberly L; Higgs, Elizabeth S; Montgomery, Joel M; Martins, Karen A
  3. Vaccines. 2022, Jul 29; 10(8):
  1. 2.   Current Status of Human Papillomavirus-Related Head and Neck Cancer: From Viral Genome to Patient Care
  2. Dong, Haoru; Shu, Xinhua; Xu, Qiang; Zhu, Chen; Kaufmann, Andreas M.; Zheng,Zhi-Ming; Albers, Andreas E.; Qian, Xu
  3. Virologica Sinica. 2021, Jun 21;
  1. 3.   Predicting the broadly neutralizing antibody susceptibility of the HIV reservoir
  2. Yu, Wen-Han; Su, David; Torabi, Julia; Fennessey,Christine; Shiakolas, Andrea; Lynch, Rebecca; Chun, Tae-Wook; Doria-Rose, Nicole; Alter, Galit; Seaman, Michael S; Keele,Brandon; Lauffenburger, Douglas A; Julg, Boris
  3. JCI insight. 2019, Sep 05; 4(17): pii: 130153.
  1. 4.   Proteomic analysis of serum, plasma, and lymph for the identification of biomarkers
  2. Meng, Z.; Veenstra, T. D.
  3. Proteomics Clinical Applications. 2007, Aug; 1(8): 747-757.
  1. 5.   Cancer-specific ligands identified from screening of peptide-display libraries
  2. Mori, T.
  3. Current Pharmaceutical Design. 2004 10(19): 2335-2343.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel